医学
多西紫杉醇
奥沙利铂
围手术期
内科学
中期分析
多中心试验
临床研究阶段
随机对照试验
外科
癌症
化疗
肿瘤科
多中心研究
结直肠癌
作者
Sylvie Lorenzen,Thorsten Oliver Götze,Peter Thuss‐Patience,Matthias Biebl,Nils Homann,Michael Schenk,Udo Lindig,Vera Heuer,Albrecht Kretzschmar,Eray Goekkurt,Georg Martin Haag,Jorge Riera‐Knorrenschild,Claus Bolling,Ralf‐Dieter Hofheinz,Tianzuo Zhan,Stefan Angermeier,Thomas Jens Ettrich,Alexander Siebenhüner,Moustafa Elshafei,Wolf O. Bechstein
摘要
This trial evaluates the addition of the PD-L1 antibody atezolizumab (ATZ) to standard-of-care fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) as a perioperative treatment for patients with resectable esophagogastric adenocarcinoma (EGA).
科研通智能强力驱动
Strongly Powered by AbleSci AI